The risk of death with the new ORAL multiple sclerosis drug fingolimod (Gilenya) is too high to use it safely.

This is false...but there are new warnings about serious adverse events with Gilenya.

Now there are reports of serious heart and other problems associated with Gilenya...including 15 deaths.

Tell patients not to panic...it’s not known if these deaths were caused by Gilenya. Send worried patients to the pharmacist.